This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

ABT Inhaled Insulin

AbbVie Inc.

Drug Names(s): KI02212, Kos Inhaled Insulin

Description: Kos Inhaled Insulin uses an inhalation delivery technology to provide aerosolized crystalline, recombinant human insulin for absorbtion through the lungs.

Deal Structure: In December 2006, Abbott Laboratories closed its acquisition of Kos Pharmaceuticals.


ABT Inhaled Insulin News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug